Stay updated on OpACIN-neo Optimal Combo Trial

Sign up to get notified when there's something new on the OpACIN-neo Optimal Combo Trial page.
Latest website image capture
Clouds background image

Latest updates to the OpACIN-neo Optimal Combo Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology across NIH content.
    Difference
    1%
    Check dated 2026-10-24T17:00:35.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the page displaying a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T16:49:34.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer’s site revision indicator changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T17:11:23.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the expected content with an access-denied message.
    Difference
    21%
    Check dated 2026-09-19T20:33:43.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page now includes 2016 U.S. NIH Grant/Contract attribution and updates the revision tag to v3.6.6, while the previous revision tag v3.6.5 is removed.
    Difference
    0.1%
    Check dated 2026-08-29T21:51:06.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    The page now shows a new site revision label (v3.6.5) replacing the previous label (v3.6.4), indicating a minor platform update.
    Difference
    0.0%
    Check dated 2026-08-08T18:16:04.000Z thumbnail image

Stay in the know with updates to OpACIN-neo Optimal Combo Trial

Enter your email address, and we'll notify you when there's something new on the OpACIN-neo Optimal Combo Trial page.